SKI Market

A+| A| A-|

Indian Indices

Sensex

76,488.96 1,073.61
( 1.42%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,466.26 22.79
(0.22%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.385578

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

30.54

113007.26

EPS(TTM)

Face Value()

Div & Yield %

45.81

0.93

Back

vipul organics ltd

Krishna Institute of Medical Sciences consolidated net profit declines 39.80% in the December 2025 quarter

Feb 07,2026

Net profit of Krishna Institute of Medical Sciences declined 39.80% to Rs 53.40 crore in the quarter ended December 2025 as against Rs 88.70 crore during the previous quarter ended December 2024. Sales rose 29.17% to Rs 997.70 crore in the quarter ended December 2025 as against Rs 772.40 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	997.70	772.40	29
OPM %	19.94	24.24	-
PBDT	147.30	179.30	-18
PBT	68.60	134.60	-49
NP	53.40	88.70	-40

76,488.96 1,073.61 ( 1.42%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,466.26 22.79 (0.22%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)